Longitudinal pathways of exclusive and polytobacco hookah use among youth, young adults and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).
Adolescent
Adult
Age Factors
Child
Cross-Sectional Studies
Humans
Longitudinal Studies
Smoking Cessation
/ statistics & numerical data
Smoking Water Pipes
Time Factors
Tobacco Products
/ statistics & numerical data
Tobacco Use
/ epidemiology
Tobacco, Waterpipe
/ statistics & numerical data
United States
/ epidemiology
Water Pipe Smoking
/ epidemiology
Young Adult
non-cigarette tobacco products
prevention
surveillance and monitoring
Journal
Tobacco control
ISSN: 1468-3318
Titre abrégé: Tob Control
Pays: England
ID NLM: 9209612
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
13
01
2020
revised:
21
01
2020
accepted:
27
01
2020
entrez:
24
4
2020
pubmed:
24
4
2020
medline:
3
6
2021
Statut:
ppublish
Résumé
The goal of this study is to examine cross-sectional rates of use and longitudinal pathways of hookah use among US youth (ages 12-17), young adults (ages 18-24), and adults 25+ (ages 25 and older). Data were drawn from the first three waves (2013-2016) of the Population Assessment of Tobacco and Health Study, a nationally representative, longitudinal cohort study of US adults and youth. Respondents with data at all three waves (youth, n=11 046; young adults, n=6478; adults 25+, n=17 188) were included in longitudinal analyses. Young adults had higher ever, past 12-month (P12M) and past 30-day cross-sectional prevalence of hookah use at each wave than youth or adults 25+. The majority of Wave 1 (W1) hookah users were P12M users of other tobacco products (youth: 73.9%, young adults: 80.5%, adults 25+: 83.2%). Most youth and adult W1 P12M hookah users discontinued use in Wave 2 or Wave 3 (youth: 58.0%, young adults: 47.5%, adults 25+: 63.4%). Most W1 P12M hookah polytobacco users used cigarettes (youth: 49.4%, young adults: 59.4%, adults 25+: 63.2%) and had lower rates of quitting all tobacco than exclusive hookah users or hookah polytobacco users who did not use cigarettes. Hookah use is more common among young adults than among youth or adults 25+. Discontinuing hookah use is the most common pathway among exclusive or polytobacco hookah users. Understanding longitudinal transitions in hookah use is important in understanding behavioural outcomes at the population level.
Identifiants
pubmed: 32321849
pii: tobaccocontrol-2020-055625
doi: 10.1136/tobaccocontrol-2020-055625
pmc: PMC7523186
mid: NIHMS1604096
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
s155-s162Subventions
Organisme : NIDA NIH HHS
ID : HHSN271201100027C
Pays : United States
Informations de copyright
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: WMC reports long-term stock holdings in General Electric Company, 3M Company, and Pfizer Incorporated, unrelated to this manuscript. No financial disclosures were reported by the other authors of this paper.
Références
Indian J Chest Dis Allied Sci. 2011 Jan-Mar;53(1):25-8
pubmed: 21446221
Toxicol Lett. 2013 May 23;219(2):133-42
pubmed: 23454654
MMWR Morb Mortal Wkly Rep. 2015 Apr 17;64(14):381-5
pubmed: 25879896
Nicotine Tob Res. 2018 Aug 14;20(suppl_1):S88-S98
pubmed: 30125019
Health Educ Behav. 2016 Jun;43(3):328-36
pubmed: 26304709
Subst Use Misuse. 2017 Jan 2;52(1):63-70
pubmed: 27668728
MMWR Morb Mortal Wkly Rep. 2014 Jun 27;63(25):542-7
pubmed: 24964880
Int J Epidemiol. 2017 Feb 1;46(1):32-43
pubmed: 27075769
Tob Control. 2020 May;29(Suppl 3):s139-s146
pubmed: 32321847
Tob Control. 2020 May;29(Suppl 3):s191-s202
pubmed: 32321853
Nicotine Tob Res. 2019 Nov 19;21(12):1590-1599
pubmed: 29961895
Addict Behav. 2017 Jun;69:78-86
pubmed: 28161620
Asian Pac J Cancer Prev. 2011;12(2):519-24
pubmed: 21545223
Fed Regist. 2016 May 10;81(90):28973-9106
pubmed: 27192730
Tob Control. 2020 May;29(Suppl 3):s163-s169
pubmed: 32321850
Addict Behav. 2013 Nov;38(11):2751-60
pubmed: 23934006
MMWR Morb Mortal Wkly Rep. 2016 Jul 15;65(27):685-91
pubmed: 27416365
Vital Health Stat 2. 1969 Jan;(31):1-24
pubmed: 5306564
Prev Med. 2014 May;62:14-9
pubmed: 24440684
Tob Control. 2017 Jan;26(1):92-97
pubmed: 27165994
J Environ Public Health. 2012;2012:989474
pubmed: 22654922
Pediatrics. 2018 Aug;142(2):
pubmed: 29967055
Public Health Rep. 2016 Jan-Feb;131(1):76-85
pubmed: 26843673
Nicotine Tob Res. 2012 Oct;14(10):1145-53
pubmed: 22318687
Nicotine Tob Res. 2013 Jan;15(1):29-35
pubmed: 22641433
Inhal Toxicol. 2012 Aug;24(10):667-75
pubmed: 22906173
MMWR Morb Mortal Wkly Rep. 2019 Feb 15;68(6):157-164
pubmed: 30763302
MMWR Morb Mortal Wkly Rep. 2018 Jun 08;67(22):629-633
pubmed: 29879097
Nicotine Tob Res. 2017 Nov 01;19(11):1345-1350
pubmed: 28013271
Tob Control. 2019 Nov;28(6):663-668
pubmed: 30297373
Tob Control. 2017 Jul;26(4):371-378
pubmed: 27507901
J Med Toxicol. 2017 Jun;13(2):193-194
pubmed: 28484988
Am J Health Behav. 2017 May 1;41(3):240-247
pubmed: 28376968
Prev Med. 2015 Feb;71:88-93
pubmed: 25535678
Tob Control. 2020 May;29(Suppl 3):s216-s226
pubmed: 32321855
Pediatrics. 2014 Aug;134(2):227-34
pubmed: 25002664
Tob Control. 2020 May;29(Suppl 3):s203-s215
pubmed: 32321854
BMC Public Health. 2013 Apr 05;13:302
pubmed: 23560649
Int J Environ Res Public Health. 2018 Nov 09;15(11):
pubmed: 30423998
Addict Behav. 2012 Feb;37(2):221-4
pubmed: 22037255
Circulation. 2019 May 7;139(19):e917-e936
pubmed: 30845826
N Engl J Med. 2017 Jan 26;376(4):342-353
pubmed: 28121512
Tob Control. 2020 May;29(Suppl 3):s170-s177
pubmed: 32321851
Tob Control. 2020 May;29(Suppl 3):s147-s154
pubmed: 32321848